Q Fever Market Size

  • Report ID: 4118
  • Published Date: Aug 13, 2024
  • Report Format: PDF, PPT

Q Fever Market Size

Q Fever Market size was valued at USD 527.4 million in 2023 and is likely to reach USD 1 billion by 2036, registering around 5.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of Q fever is assessed at USD 548.92 million. The growth of the market can be ascribed to factors, such as, increasing patient pool owing to the higher prevalence of Q fever, growing demand for enhanced diagnostic solutions, and raising awareness of acute & chronic Q fever prevention. Q fever, also designated as Query fever, is an infectious fever that can spread via contact with farm animals, such as, sheep, cattle, and others. Moreover, based on a report published by the National Library of Medicine (NLM) in 2020, about 50 people out of 100,000 suffer from acute Q fever annually while 1 person out of 1,000,000 obtains chronic Q fever in one year. Furthermore, people with low immunity, farmworkers, and old age people are more likely to get Q fever. As per data provided by World Bank, in 2020, 723,484,050 people were stated to be aged 65 years or above. All these factors are projected to influence the global Q fever market positively during the forecast period.  


Q Fever Market Graph
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4118
  • Published Date: Aug 13, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of Q fever is assessed at USD 548.92 million.

Q Fever Market size was valued at USD 527.4 million in 2023 and is likely to reach USD 1 billion by 2036, registering around 5.1% CAGR during the forecast period i.e., between 2024-2036. Growing patient pool on account of the higher prevalence of Q fever, rising demand for enhanced diagnostic solutions, and increasing awareness of acute & chronic Q fever prevention will propel the market growth.

North America industry is estimated to account for largest revenue share by 2036, due to increasing awareness of infectious diseases, growing demand for enhanced diagnostic facilities, and a higher prevalence of Q fever in the region.

The major players in the market are Pfizer Inc., Arix Bioscience plc, Yashica Pharmaceuticals Pvt. Ltd, Merck KGaA, Melinta Therapeutics LLC, Teva Pharmaceutical Ltd., Bayer AG, and Johnson & Johnson Services, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample